COVID-19 has transformed the delivery of health care in ways many of us could not have imagined. But as the crisis continues and evolves, it’s important to learn from early lessons COVID-19 taught us.
In a series of blogs and videos, senior leaders at SCA Pharma address the pandemic’s impact on quality, operations, dynamic sales and product demand, and overall customer service during these challenging times.
First, CEO Milton Boyer describes his priorities for bolstering supply chains and satisfying customer needs. And he looks to what a “new normal” might look like in our business moving forward.
Click here to watch the video.
You can download our updated list of medications to treat COVID-19 here.
SCA Pharma is an FDA 503B outsourcing facility providing the highest quality sterile admixtures and pre-filled syringes. Licensed in all 50 states, SCA Pharma specializes in preparing sterile pharmaceuticals customized for hospital pharmacies and healthcare facilities nationwide.
Headquartered in Little Rock, Arkansas, SCA Pharma has two state-of-the-art production facilities in both Arkansas and Connecticut. For more information, contact marketing@scapharma.com.
This post is related to:
Patient Care: Personalized Wellness, Point-of-Care Services
